$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] Improving the Safety of Mesenchymal Stem Cell-Based Ex Vivo Therapy Using Herpes Simplex Virus Thymidine Kinase 원문보기

Molecules and cells, v.45 no.7, 2022년, pp.479 - 494  

Bashyal, Narayan (Department of Anatomy, Ajou University School of Medicine) ,  Lee, Tae-Young (Research Center, Cell&Brain Co., Ltd.) ,  Chang, Da-Young (Research Center, Cell&Brain Co., Ltd.) ,  Jung, Jin-Hwa (Department of Anatomy, Ajou University School of Medicine) ,  Kim, Min Gyeong (Department of Anatomy, Ajou University School of Medicine) ,  Acharya, Rakshya (Department of Anatomy, Ajou University School of Medicine) ,  Kim, Sung-Soo (Department of Anatomy, Ajou University School of Medicine) ,  Oh, Il-Hoan (Department of Medical Lifescience, The Catholic University of Korea, College of Medicine) ,  Suh-Kim, Haeyoung (Department of Anatomy, Ajou University School of Medicine)

Abstract AI-Helper 아이콘AI-Helper

Human mesenchymal stem cells (MSCs) are multipotent stem cells that have been intensively studied as therapeutic tools for a variety of disorders. To enhance the efficacy of MSCs, therapeutic genes are introduced using retroviral and lentiviral vectors. However, serious adverse events (SAEs) such as...

Keyword

참고문헌 (67)

  1. al-Shawi R. Burke J. Wallace H. Jones C. Harrison S. Buxton D. Maley S. Chandley A. Bishop J.O. 1991 The herpes simplex virus type 1 thymidine kinase is expressed in the testes of transgenic mice under the control of a cryptic promoter Mol. Cell. Biol. 11 4207 4216 10.1128/mcb.11.8.4207-4216.1991 1712906 

  2. Aurich H. Sgodda M. Kaltwasser P. Vetter M. Weise A. Liehr T. Brulport M. Hengstler J.G. Dollinger M.M. Fleig W.E. 2009 Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo Gut 58 570 581 10.1136/gut.2008.154880 19022918 

  3. Balzarini J. Liekens S. Solaroli N. El Omari K. Stammers D.K. Karlsson A. 2006 Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation J. Biol. Chem. 281 19273 19279 10.1074/jbc.M600414200 16702226 

  4. Belizário J.E. 2009 Immunodeficient mouse models: an overview Open Immunol. J. 2 79 85 10.2174/1874226200902010079 

  5. Beltinger C. Fulda S. Kammertoens T. Meyer E. Uckert W. Debatin K.M. 1999 Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases Proc. Natl. Acad. Sci. U. S. A. 96 8699 8704 10.1073/pnas.96.15.8699 10411938 

  6. Black M.E. Kokoris M.S. Sabo P. 2001 Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing Cancer Res. 61 3022 3026 11306482 

  7. Black M.E. Newcomb T.G. Wilson H.M. Loeb L.A. 1996 Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy Proc. Natl. Acad. Sci. U. S. A. 93 3525 3529 10.1073/pnas.93.8.3525 8622970 

  8. Cartier N. Hacein-Bey-Abina S. Bartholomae C.C. Veres G. Schmidt M. Kutschera I. Vidaud M. Abel U. Dal-Cortivo L. Caccavelli L. 2009 Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy Science 326 818 823 10.1126/science.1171242 19892975 

  9. Cen S. Li J. Cai Z. Pan Y. Sun Z. Li Z. Ye G. Zheng G. Li M. Liu W. 2020 TRAF4 acts as a fate checkpoint to regulate the adipogenic differentiation of MSCs by activating PKM2 EBioMedicine 54 102722 10.1016/j.ebiom.2020.102722 32268273 

  10. Chang D.Y. Jung J.H. Kim A.A. Marasini S. Lee Y.J. Paek S.H. Kim S.S. Suh-Kim H. 2020 Combined effects of mesenchymal stem cells carrying cytosine deaminase gene with 5-fluorocytosine and temozolomide in orthotopic glioma model Am. J. Cancer Res. 10 1429 1441 32509389 

  11. Chang D.Y. Yoo S.W. Hong Y. Kim S. Kim S.J. Yoon S.H. Cho K.G. Paek S.H. Lee Y.D. Kim S.S. 2010 The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase Int. J. Cancer 127 1975 1983 10.1002/ijc.25383 20473873 

  12. Cicalese M.P. Ferrua F. Castagnaro L. Rolfe K. De Boever E. Reinhardt R.R. Appleby J. Roncarolo M.G. Aiuti A. 2018 Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety Mol. Ther. 26 917 931 10.1016/j.ymthe.2017.12.022 29433935 

  13. De Ravin S.S. Wu X. Moir S. Anaya-O'Brien S. Kwatemaa N. Littel P. Theobald N. Choi U. Su L. Marquesen M. 2016 Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency Sci. Transl. Med. 8 335ra357 10.1126/scitranslmed.aad8856 27099176 

  14. Dilger N. Neehus A.L. Grieger K. Hoffmann A. Menssen M. Ngezahayo A. 2020 Gap junction dependent cell communication is modulated during transdifferentiation of mesenchymal stem/stromal cells towards neuron-like cells Front. Cell Dev. Biol. 8 869 10.3389/fcell.2020.00869 32984345 

  15. Dos Santos J.F. Borçari N.R. da Silva Araújo M. Nunes V.A. 2019 Mesenchymal stem cells differentiate into keratinocytes and express epidermal kallikreins: towards an in vitro model of human epidermis J. Cell. Biochem. 120 13141 13155 10.1002/jcb.28589 30891818 

  16. Field A.K. Davies M.E. DeWitt C. Perry H.C. Liou R. Germershausen J. Karkas J.D. Ashton W.T. Johnston D.B. Tolman R.L. 1983 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication Proc. Natl. Acad. Sci. U. S. A. 80 4139 4143 10.1073/pnas.80.13.4139 6306664 

  17. Fitzgerald J.C. Weiss S.L. Maude S.L. Barrett D.M. Lacey S.F. Melenhorst J.J. Shaw P. Berg R.A. June C.H. Porter D.L. 2017 Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia Crit. Care Med. 45 e124 e131 10.1097/CCM.0000000000002053 27632680 

  18. Greco R. Oliveira G. Stanghellini M.T. Vago L. Bondanza A. Peccatori J. Cieri N. Marktel S. Mastaglio S. Bordignon C. 2015 Improving the safety of cell therapy with the TK-suicide gene Front. Pharmacol. 6 95 10.3389/fphar.2015.00095 25999859 

  19. Hacein-Bey-Abina S. Le Deist F. Carlier F. Bouneaud C. Hue C. De Villartay J.P. Thrasher A.J. Wulffraat N. Sorensen R. Dupuis-Girod S. 2002 Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy N. Engl. J. Med. 346 1185 1193 10.1056/NEJMoa012616 11961146 

  20. Hacein-Bey-Abina S. Pai S.Y. Gaspar H.B. Armant M. Berry C.C. Blanche S. Bleesing J. Blondeau J. de Boer H. Buckland K.F. 2014 A modified γ-retrovirus vector for X-linked severe combined immunodeficiency N. Engl. J. Med. 371 1407 1417 10.1056/NEJMoa1404588 25295500 

  21. Hall S.J. Sanford M.A. Atkinson G. Chen S.H. 1998 Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer Cancer Res. 58 3221 3225 9699645 

  22. Hetzel M. Suzuki T. Hashtchin A.R. Arumugam P. Carey B. Schwabbauer M. Kuhn A. Meyer J. Schambach A. Van Der Loo J. 2017 Function and safety of lentivirus-mediated gene transfer for CSF2RA-deficiency Hum. Gene Ther. Methods 28 318 329 10.1089/hgtb.2017.092 28854814 

  23. Huang P. Wang L. Li Q. Xu J. Xu J. Xiong Y. Chen G. Qian H. Jin C. Yu Y. 2019 Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance Stem Cell Res. Ther. 10 300 10.1186/s13287-019-1353-3 31601262 

  24. Kalos M. Levine B.L. Porter D.L. Katz S. Grupp S.A. Bagg A. June C.H. 2011 T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia Sci. Transl. Med. 3 95ra73 10.1126/scitranslmed.3002842 21832238 

  25. Kan I. Ben-Zur T. Barhum Y. Levy Y.S. Burstein A. Charlow T. Bulvik S. Melamed E. Offen D. 2007 Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression Neurosci. Lett. 419 28 33 10.1016/j.neulet.2007.03.070 17475405 

  26. Kim S.S. Choi J.M. Kim J.W. Ham D.S. Ghil S.H. Kim M.K. Kim-Kwon Y. Hong S.Y. Ahn S.C. Kim S.U. 2005 cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK Neuroreport 16 1357 1361 10.1097/01.wnr.0000175243.12966.f5 16056139 

  27. Kim S.S. Kim B.J. Suh-Kim H. 2003 The efficient gene delivery into human mesenchymal stem cells using retroviral vectors Korean J. Anat. 36 381 387 

  28. Kim S.S. Yoo S.W. Park T.S. Ahn S.C. Jeong H.S. Kim J.W. Chang D.Y. Cho K.G. Kim S.U. Huh Y. 2008 Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain Stem Cells 26 2217 2228 10.1634/stemcells.2008-0108 18617687 

  29. Le Blanc K. Rasmusson I. Sundberg B. Götherström C. Hassan M. Uzunel M. Ringdén O. 2004 Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 1439 1441 10.1016/S0140-6736(04)16104-7 15121408 

  30. Le Blanc K. Tammik C. Rosendahl K. Zetterberg E. Ringdén O. 2003 HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells Exp. Hematol. 31 890 896 10.1016/S0301-472X(03)00110-3 14550804 

  31. Lee S.H. Jin K.S. Bang O.Y. Kim B.J. Park S.J. Lee N.H. Yoo K.H. Koo H.H. Sung K.W. 2015 Differential migration of mesenchymal stem cells to ischemic regions after middle cerebral artery occlusion in rats PLoS One 10 e0134920 10.1371/journal.pone.0134920 26241653 

  32. Lee T.Y. Cho I.S. Bashyal N. Naya F.J. Tsai M.J. Yoon J.S. Choi J.M. Park C.H. Kim S.S. Suh-Kim H. 2020 ERK regulates NeuroD1-mediated neurite outgrowth via proteasomal degradation Exp. Neurobiol. 29 189 206 10.5607/en20021 32606250 

  33. Lin P. Lin Y. Lennon D.P. Correa D. Schluchter M. Caplan A.I. 2012 Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities Stem Cells Transl. Med. 1 886 897 10.5966/sctm.2012-0086 23283550 

  34. Locke F.L. Ghobadi A. Jacobson C.A. Miklos D.B. Lekakis L.J. Oluwole O.O. Lin Y. Braunschweig I. Hill B.T. Timmerman J.M. 2019 Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial Lancet Oncol. 20 31 42 10.1016/S1470-2045(18)30864-7 30518502 

  35. Ma T. Gong K. Ao Q. Yan Y. Song B. Huang H. Zhang X. Gong Y. 2013 Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer's disease mice Cell Transplant. 22 Suppl 1 S113 S126 10.3727/096368913X672181 24070198 

  36. Marasini S. Chang D.Y. Jung J.H. Lee S.J. Cha H.L. Suh-Kim H. Kim S.S. 2017 Effects of adenoviral gene transduction on the stemness of human bone marrow mesenchymal stem cells Mol. Cells 40 598 605 10.14348/molcells.2017.0095 28835020 

  37. Marsden H.S. Haarr L. Preston C.M. 1983 Processing of herpes simplex virus proteins and evidence that translation of thymidine kinase mRNA is initiated at three separate AUG codons J. Virol. 46 434 445 10.1128/jvi.46.2.434-445.1983 6302312 

  38. Mazzini L. Fagioli F. Boccaletti R. Mareschi K. Oliveri G. Olivieri C. Pastore I. Marasso R. Madon E. 2003 Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4 158 161 10.1080/14660820310014653 13129802 

  39. McGarrity G.J. Hoyah G. Winemiller A. Andre K. Stein D. Blick G. Greenberg R.N. Kinder C. Zolopa A. Binder-Scholl G. 2013 Patient monitoring and follow-up in lentiviral clinical trials J. Gene Med. 15 78 82 10.1002/jgm.2691 23322669 

  40. Mesnil M. Yamasaki H. 2000 Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication Cancer Res. 60 3989 3999 10945596 

  41. Naldini L. 2011 Ex vivo gene transfer and correction for cell-based therapies Nat. Rev. Genet. 12 301 315 10.1038/nrg2985 21445084 

  42. Neelapu S.S. Locke F.L. Bartlett N.L. Lekakis L.J. Miklos D.B. Jacobson C.A. Braunschweig I. Oluwole O.O. Siddiqi T. Lin Y. 2017 Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma N. Engl. J. Med. 377 2531 2544 10.1056/NEJMoa1707447 29226797 

  43. Park J.S. Chang D.Y. Kim J.H. Jung J.H. Park J. Kim S.H. Lee Y.D. Kim S.S. Suh-Kim H. 2013 Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells Exp. Mol. Med. 45 e10 10.1038/emm.2013.21 23429359 

  44. Park J.S. Suryaprakash S. Lao Y.H. Leong K.W. 2015 Engineering mesenchymal stem cells for regenerative medicine and drug delivery Methods 84 3 16 10.1016/j.ymeth.2015.03.002 25770356 

  45. Pittenger M.F. Mackay A.M. Beck S.C. Jaiswal R.K. Douglas R. Mosca J.D. Moorman M.A. Simonetti D.W. Craig S. Marshak D.R. 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 143 147 10.1126/science.284.5411.143 10102814 

  46. Poudineh M. Wang Z. Labib M. Ahmadi M. Zhang L. Das J. Ahmed S. Angers S. Kelley S.O. 2018 Three-dimensional nanostructured architectures enable efficient neural differentiation of mesenchymal stem cells via mechanotransduction Nano Lett. 18 7188 7193 10.1021/acs.nanolett.8b03313 30335391 

  47. Preuss E. Treschow A. Newrzela S. Brücher D. Weber K. Felldin U. Alici E. Gahrton G. von Laer D. Dilber M.S. 2010 TK.007: a novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy Hum. Gene Ther. 21 929 941 10.1089/hum.2009.042 20201626 

  48. Ramos C.A. Asgari Z. Liu E. Yvon E. Heslop H.E. Rooney C.M. Brenner M.K. Dotti G. 2010 An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies Stem Cells 28 1107 1115 10.1002/stem.433 20506146 

  49. Reardon J.E. 1989 Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition J. Biol. Chem. 264 19039 19044 10.1016/S0021-9258(19)47263-3 2553730 

  50. Rothenburger T. Thomas D. Schreiber Y. Wratil P.R. Pflantz T. Knecht K. Digianantonio K. Temple J. Schneider C. Baldauf H.M. 2021 Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells J. Exp. Clin. Cancer Res. 40 317 10.1186/s13046-021-02093-4 34641952 

  51. Schuster S.J. Bishop M.R. Tam C.S. Waller E.K. Borchmann P. McGuirk J.P. Jäger U. Jaglowski S. Andreadis C. Westin J.R. 2019 Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma N. Engl. J. Med. 380 45 56 10.1056/NEJMoa1804980 30501490 

  52. Sgodda M. Aurich H. Kleist S. Aurich I. König S. Dollinger M.M. Fleig W.E. Christ B. 2007 Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo Exp. Cell Res. 313 2875 2886 10.1016/j.yexcr.2007.05.020 17574236 

  53. Shin J.W. Ryu S. Ham J. Jung K. Lee S. Chung D.H. Kang H.R. Kim H.Y. 2021 Mesenchymal stem cells suppress severe asthma by directly regulating Th2 cells and type 2 innate lymphoid cells Mol. Cells 44 580 590 10.14348/molcells.2021.0101 34462397 

  54. Suzuki M. McHugh J. Tork C. Shelley B. Hayes A. Bellantuono I. Aebischer P. Svendsen C.N. 2008 Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS Mol. Ther. 16 2002 2010 10.1038/mt.2008.197 18797452 

  55. Szaraz P. Gratch Y.S. Iqbal F. Librach C.L. 2017 In vitro differentiation of human mesenchymal stem cells into functional cardiomyocyte-like cells J. Vis. Exp. 126 55757 10.3791/55757 28829419 

  56. Tani K. 2016 Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world Int. J. Hematol. 104 42 72 10.1007/s12185-016-2030-2 27289360 

  57. Tomayko M.M. Reynolds C.P. 1989 Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother. Pharmacol. 24 148 154 10.1007/BF00300234 2544306 

  58. Unsal I.O. Ginis Z. Pinarli F.A. Albayrak A. Cakal E. Sahin M. Delibasi T. 2015 Comparison of therapeutic characteristics of islet cell transplantation simultaneous with pancreatic mesenchymal stem cell transplantation in rats with Type 1 diabetes mellitus Stem Cell Rev. Rep. 11 526 532 10.1007/s12015-014-9563-7 25297071 

  59. Valiunas V. Doronin S. Valiuniene L. Potapova I. Zuckerman J. Walcott B. Robinson R.B. Rosen M.R. Brink P.R. Cohen I.S. 2004 Human mesenchymal stem cells make cardiac connexins and form functional gap junctions J. Physiol. 555 617 626 10.1113/jphysiol.2003.058719 14766937 

  60. van Dillen I.J. Mulder N.H. Vaalburg W. de Vries E.F. Hospers G.A. 2002 Influence of the bystander effect on HSV-tk/GCV gene therapy. A review Curr. Gene Ther. 2 307 322 10.2174/1566523023347733 12189718 

  61. Wang F. Yasuhara T. Shingo T. Kameda M. Tajiri N. Yuan W.J. Kondo A. Kadota T. Baba T. Tayra J.T. 2010 Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha BMC Neurosci. 11 52 10.1186/1471-2202-11-52 20420688 

  62. Wang M. Munoz J. Goy A. Locke F.L. Jacobson C.A. Hill B.T. Timmerman J.M. Holmes H. Jaglowski S. Flinn I.W. 2020 KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma N. Engl. J. Med. 382 1331 1342 10.1056/NEJMoa1914347 32242358 

  63. Xin H. Li Y. Cui Y. Yang J.J. Zhang Z.G. Chopp M. 2013 Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats J. Cereb. Blood Flow Metab. 33 1711 1715 10.1038/jcbfm.2013.152 23963371 

  64. Yang H. Yang H. Xie Z. Wei L. Bi J. 2013 Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice PLoS One 8 e69129 10.1371/journal.pone.0069129 23935936 

  65. Zhang X. Chen J. Liu A. Xu X. Xue M. Xu J. Yang Y. Qiu H. Guo F. 2018 Stable overexpression of p130/E2F4 affects the multipotential abilities of bone-marrow-derived mesenchymal stem cells J. Cell. Physiol. 233 9739 9749 10.1002/jcp.26926 29987913 

  66. Zhang Y. Huang X. Yuan Y. 2017 MicroRNA-410 promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells through down-regulating Wnt3a Am. J. Transl. Res. 9 136 145 28123640 

  67. Zhang Z. Lin J. Chu J. Ma Y. Zeng S. Luo Q. 2008 Activation of caspase-3 noninvolved in the bystander effect of the herpes simplex virus thymidine kinase gene/ganciclovir (HSV-tk/GCV) system J. Biomed. Opt. 13 031209 10.1117/1.2937830 18601533 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로